The Motley Fool, founded in 1993 by brothers David and Tom Gardner, is a multimedia financial services company dedicated to empowering individual investors with accessible, actionable advice. Headquartered in Alexandria, Virginia, the company offers a range of products, including stock recommendations, investment research, and personal finance guidance, through its popular website, newsletters, podcasts, and premium subscription services.
Why The Trade Desk Fell Again Today Yesterday's bad news was compounded by analyst downgrades today.
Here's Why Ovid Therapeutics Stock Popped Higher Today Ovid stock surged 18% following positive Phase 1 data for OV329, and investors are getting excited about a forthcoming Phase 2.
Up 4,300%, but the Biggest Reason to Buy Carvana Was Heavily Overlooked Carvana's fourth-quarter net income was boosted by the release of its valuation allowance. What does that mean to investors?
GigaCloud Technology CEO Sold 90,000 Company Shares for $3.8 Million. Is the Stock a Buy or Sell? GigaCloud Technology, a global B2B ecommerce platform for large goods, reported significant insider selling in its latest SEC filing.
REET Offers Greater Scale Than GQRE Expense ratios, yield, and fund size set these global real estate ETFs apart—see how these differences may impact your investing strategy.
Marvell Technology vs. Broadcom: Which Custom AI Chip Stock Has More Upside? These two companies are benefiting significantly from growing adoption of custom artificial intelligence (AI) processors by hyperscalers and AI companies.
3 Reasons Costco Stock Deserves to Trade at a Sky-High Valuation Investors often scoff at the stock's premium price tag. But if there's any business that deserves such a high valuation multiple, it's this one.
Will Micron Technology Be the Next Tech Stock to Reach a $1 Trillion Market Cap? Micron's business has been soaring due to strong demand for its storage and memory products.
Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit Clinical-stage biotech Dianthus Therapeutics develops antibody therapies for severe autoimmune and neuromuscular conditions.
Amazon Stock Investors Just Got Fantastic News From CEO Andy Jassy The chief executive just provided a stunning forecast for the company's future growth.
Down 20%, Is Oracle a No-Brainer AI Buy? Oracle's cloud infrastructure business is delivering mind-boggling growth.
Market Indexes Dip as the Fed Takes Center Stage Why are the major indexes falling today? Here is how persistent inflation and the latest Fed decision are shaping the market's move.
GQRE Offers Higher Yield While HAUZ Is More Affordable Explore how these two global real estate ETFs differ in costs, holdings, and risk profiles to help refine your investment strategy.
Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit This Boston-based biotech develops therapies for neurological disorders, with a pipeline targeting depression, tremor, and rare epilepsies.
Could the Middle East War Cause a Major Market Sell-Off This Year? Deutsche Bank has identified three factors that could trigger a war-related recession.
This Telecom Stock Is Up 19% This Past Year, so Why Did One Fund Just Exit? Operating nationwide, Telephone and Data Systems delivers broadband and cloud-based services to a diverse U.S. customer base.
Buy These 3 Semiconductor Stocks Now and Thank Yourself in a Decade These companies are a fantastic way to profit from a surging semiconductor industry as artificial intelligence continues to change the world.
2 Energy Stocks That Could Be Bigger Winners Than Crude Oil Ongoing geopolitical conflict in the Persian Gulf threatens to structurally change how the energy markets function, and that would lead to a permanent benefit for these two companies.
2 Growth Stocks That Could Go Parabolic These AI-adjacent companies are growing at a rapid pace and have massive opportunities.
Greenhouse Funds Dumps 803,000 Blackbaud Shares Worth $51.6 Million Blackbaud delivers cloud-based software to nonprofits, education, and healthcare, supporting fundraising and financial operations.
This Staffing Stock Has Plunged 56% in a Year, but Does a Nearly $10 Million Buy Signal a Turnaround Looming? ManpowerGroup delivers workforce and talent solutions to clients in over 75 countries, spanning recruitment, training, and HR outsourcing.
Why Newmont Stock Is Tumbling Today While no one knows where gold price will head next, your strategy for Newmont stock should be clear.
HAUZ vs. RWX: Which Real Estate ETF Has the Edge? Lower fees, broader holdings, and higher yield set these global real estate ETFs apart—see how their strategies could impact your portfolio.
Why Can Some Retirees Work and Still Collect Social Security Benefits and Others Can't? Working while collecting Social Security can be a financial lifeline, but not all retirees can do it without impacting their benefits.
Top Holding at 10%: Why a Nearly $60 Million Move Into This Oilfield Stock Stands Out Cactus delivers wellhead equipment and field services to oil and gas operators across key unconventional markets worldwide.
Ardsley Dumps 440,000 Hut 8 Shares Worth $19.4 Million Hut 8 operates large-scale data centers supporting Bitcoin mining and high-performance computing for institutional clients.
U.S. REIT Exposure or Global Real Estate Diversification? VNQ vs. RWX The Vanguard Real Estate ETF (VNQ) centers on U.S. REITs and the domestic property market, while the SPDR Dow Jones International Real Estate ETF (RWX) reaches into real estate companies across global markets. This comparison explores how those differences influence income, rate sensitivity, and how real estate cycles play out in different parts of the world.
Better Buy: Bitcoin or AI? The "sell Bitcoin, buy AI" trade is winning right now. But is it the right move over the long haul?
This Energy Stock Returned $131 Million to Shareholders Last Quarter, but One Fund Still Sold Off $48 Million in Shares Viper Energy manages mineral interests in major U.S. shale basins, with a focus on oil and natural gas royalties and income generation.
REET Delivers a Higher Yield, But ICF Provides Greater Exposure to the U.S. REIT Market Fee structure, yield, and diversification set these two real estate ETFs apart—here’s what investors should weigh before choosing.
VNQI vs. RWX: Which International Real Estate ETF Belongs in Your Portfolio? See how VNQI and RWX differ on fees, diversification, and portfolio focus -- all key factors for international real estate ETF investors.
3 Monster Dividend Stocks to Hold for the Next 10 Years These dividend stocks could generate monster total returns over the next decade.
This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain Axsome Therapeutics develops therapies for central nervous system disorders, with a late-stage pipeline targeting major unmet medical needs.
The Best Stocks to Invest $10,000 in Right Now These three AI stocks look like great buys at the moment.
Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet? This clinical-stage biotech develops therapies targeting the root cause of cystic fibrosis, with a pipeline focused on CFTR modulators.
What to Make of VR Adviser's Big Ocular Therapeutix Sell-Down This ophthalmic biopharma firm develops sustained drug delivery therapies for eye diseases, targeting both U.S. and global markets.
This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names This clinical-stage biopharma targets neurological and psychiatric disorders with a pipeline of novel therapeutics advancing through trials.
The 3 Things That Matter Most for MercadoLibre Right Now After MercadoLibre's latest earnings, there are a few important things to watch.
A Letter to Disney's New CEO Josh D'Amaro takes over the media giant at this week's annual shareholder meeting. It's an exciting and frightening opportunity.
RWR vs. REET: Same Blue-Chip REIT Foundation, Different Geographic Strategies Compare how global diversification, fund size, and cost structure set these two real estate ETFs apart for investors.
The Trump Administration Just Rewarded Archer Aviation and Joby Aviation. Which One Is the Big Winner? The rival eVTOL air taxi companies agree that this is a big deal. But which one got the short end of the stick?
REET vs. HAUZ: One Fund Anchors in U.S. REITs, the Other Invests Entirely Abroad Expense ratios, dividend yields, and geographic focus set these real estate ETFs apart for investors seeking tailored global exposure.
4 Dividend Energy Stocks to Buy in March Recent events are turning the energy sector on its head, but these stocks still offer safe dividend income.
GQRE vs. VNQ: For These Real Estate ETFs, Is a Higher Yield Worth the Extra Cost? Explore how differing fees, global diversification, and liquidity shape the real estate ETF landscape for investors.
Why Your S&P 500 ETF Could Rapidly Include SpaceX SpaceX could soon be a public company and that could lead to new looks for some of the largest ETFs.
2 Real Estate ETFs With Opposite Strategies: HAUZ Spans the Globe, ICF Bets Big on the U.S. Explore how these two real estate ETFs differ in cost, diversification, and risk to help refine your portfolio strategy.
